MTOR and cancer: Other processes altered under diabetic conditions point to a regulation of carcinogenesis, as the epidermal growth factor receptor (ErbB) and the PI3K–Akt signaling pathways, both in the upstream cascade of mTOR, and regulators of proliferation in several cancers including CC (Herbst, 2004).